Featured Content from the Newsletter
CRS Premeeting Workshop on the Regulatory Landscape for Therapeutic Biologics
The workshop is aimed at providing a snapshot of the recent evolution in product development and regulatory evaluation of therapeutic biologics. In addition to therapeutic biologics, the workshop will also introduce the regulatory considerations for complex drug substances including peptides, which typically have no more than 40 amino acids, as well as related drug delivery systems such as implants and microspheres for parenteral administration. The co-chairs, Hong Wen and Yan Wang, prepared this exciting workshop by assembling a great team of experts from around the world.